PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31196016-0	2019	Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.	carglumic acid	52-66	monocyte to macrophage differentiation associated	Homo sapiens	111-139	
31196016-3	2019	Here we report the rationale and design of a phase IIIb trial that is aimed at determining the long-term efficacy and safety of carglumic acid in the management of PA and MMA.	carglumic acid	128-142	monocyte to macrophage differentiation associated	Homo sapiens	171-174	
31196016-9	2019	Although retrospective studies have suggested that long-term carglumic acid may be beneficial in the management of PA and MMA, current literature lacks evidence for this indication.	carglumic acid	61-75	monocyte to macrophage differentiation associated	Homo sapiens	122-125	
31196016-10	2019	This clinical trial will determine the long-term safety and efficacy of carglumic acid in the management of PA and MMA.	carglumic acid	72-86	monocyte to macrophage differentiation associated	Homo sapiens	115-118